Antenatal treatment of fetal immune thrombocytopenias

Fetal and Maternal Medicine Review

Volumn 10, Issue 1, 1998, Pages 1-19

  Skupski, Daniel W ^a,b   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Division of Maternal Fetal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; STEROID; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

BRAIN HEMORRHAGE; CLINICAL TRIAL; CORDOCENTESIS; FETUS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOASSAY; INTRAUTERINE BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; PRENATAL CARE; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VAGINAL DELIVERY;

EID: 0031871603     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539598000114     Document Type: Review

References (79)

1. Kaplan C, Morel-Kopp MC, Kroll H, Kiefel V, Schlegel N, Chesnel N et al. HPA-5b [Br(a)] neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991; 78: 425-29.
2. Karpatkin S. Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? Br J Haematol 1994; 86: 1-5.
3. Bussel JB, Zabusky MR, Berkowitz RL, McFarland, JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997; 337: 22-26.
4. Naidu S, Messmore H, Caserta V, Fine M. CNS lesions in neonatal isoimmune thrombocytopenia. Arch Neurol 1983; 40: 552-54.
5. AI platelet antigen: results of a prospective study. Br J Haematol 1990; 74: 209-15.
6. Doughty HA, Murphy MF, Metcalfe P, Campbell J, Waters AH. Feto-maternal alloimmune thrombocytopenia (FMAIT): early results of an antenatal screening programme. Br J Haematol 1993; 84 (Suppl 1): 7.
7. Kaplan C, Schlegel N, Durand-Zaleski I, Tchernia G, Blum-Noisgard C. Anti-HPA-1a materno-fetal platelet alloimmunisation: costs and benefits of a prospective routine programme. Thromb Haemost 1993; 69: 1191.
8. Williamson LM, Hadfield R, Maciver C, Ouwehand WH. An antenatal screening programme to detect pregnancies at risk of neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Vox Sang 1994; 67 (Suppl 2):3.
9. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, Uzan S, Dreyfus M, Kaplan C. Screening primiparous women and newborns for fetal/ neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol 1996; 13: 423-31.
10. Herman JH, Jumbelic MI, Ancona RJ, Kickler TS. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Fed Hematol Oncol 1986; 8: 312-17.
11. Lynch L, Bussel JB, McFarland JG, Chitkara U, Berkowitz RL. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 1992; 80; 67-71.
12. Bussel J, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Kanhai HH et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma globulin: a randomized trial of the addition of low dose steroids to IVIG in fifty-five maternal-fetal pairs. Am J Obstet Gynecol 1996; 174: 1414-23.
13. Kaplan C, Daffos F, Forestier F, Morel MC, Chesnel N, Tchernia G. Current trends in neonatal alloimmune thrombocytopenia: diagnosis and therapy. In: Kaplan-Gouet C, Schlegel M, Salmon C, McGregor J (eds). Platelet immunology: fundamental and clinical aspects. London: Colloque INSERM/John Libbey Eurotext Ltd., 1991: 206: 267-78.
14. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319; 1374-78.
15. Bussel JB, Skupski DW, McFarland JG. Fetal alloimmune thrombocytopenia: consensus and controversy. J Maternal Fetal Med 1996; 5: 281-92.
16. Menell JS, Bussel JB. Antenatal management of the thrombocytopenias. Clin Perinatol 1994; 21: 591-614.
17. Newman PJ. Nomenclature of human platelet alloantigens: a problem with the HPA system? Blood 1994; 83: 1447-51.
18. Kramer K, Bussel JB. Neonatal alloimmune thrombocytopenia: a bedside clinical index. Submitted.
19. Hessner MJ, Agostini TA, Bellissimo DB, Endean DJ, Perdon RA, Kirschbaum NE. The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders. Am J Obstet Gynecol 1997; 176: 327-33.
20. Daffos R, Forestier F, Kaplan C. Prenatal treatment of fetal alloimmune thrombocytopenia. Lancet 1988; 2: 910.
21. Bowman J, Harman C, Mentiglou S, Pollock J. Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopenia. Lancet 1992; 340: 1034.
22. Nicolini U, Rodeck CH, Kochenour NK, Greco P, Fisk NM, Letsky E. In-utero platelet transfusion for alloimmune thrombocytopenia. Lancet 1988; 2:506.
23. Nicolini U, Tannirandorn Y, Gonzalez P, Fisk NM, Beacham J, Letsky EA et al. Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia. Am J Obstet Gynecol 1990; 163: 1144-46.
24. Murphy MF, Waters AH, Doughty A, Hambley H, Mibashan RS, Nicolaides K et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transfusion Medicine 1994; 4; 281-92.
25. Murphy MF, Pullon HWH, Metcalfe P, Chapman JF, Jenkins E, Waters AH et al. Management of fetal alloimmune thrombocytopenia by weekly in utero platelet transfusions. Vox Sang 1990; 58: 45-49.
26. Paidas MJ, Berkowitz RL, Lynch L, Lockwood CJ, Lapinski R, McFarland JG et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995; 172: 475-79.
27. Kaplan C, Daffos F, Forestier F, Morel MC, Chesnel N, Tchernia G. Current trends in neonatal alloimmune thrombocytopenia: diagnosis and therapy. Platelet immunology: fundamental and clinical aspects. 1991; 206: 267-78.
28. Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood 1993; 81: 2174-79.
29. Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994; 34: 929-34.
30. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-67.
31. Pineda AA, Zylstra VSV, Clare DE, Dewanjee MK, Forstrom LA. Viability and functional integrity of washed platelets. Transfusion 1989; 29: 524-27.
32. MacGregor SN, Socol ML, Fielet BW, Sholl JT, Minogue JP. Prediction of fetoplacental blood volume in isoimmunized pregnancy. Am J Obstet Gynecol 1988; 159: 1493-97.
33. Queenan JT. Amniotic fluid analysis. In: Modern management of the Rh problem. 2nd ed. New York: Harper & Row, 1977: 73-129.
34. Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987; 157; 50-53.
35. Skupski DW, Wolf CFW, Bussel JB. Fetal and perinatal transfusion therapy. In: Petz LD, Swisher SN, Kleinman S, Spence RK, eds. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996: 607-32.
36. Rodeck CH, Roberts LJ. Successful treatment of fetal cardiac arrest by left ventricular exchange transfusion. Fetal Diagn Ther 1994; 9: 213-17.
37. Kaplan C, Forestier F, Cox WL, Lyon-Caen D, Dupuy-Montbrun MC, Salmon C. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988; 72: 340-43.
38. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981; 304: 1135-47.
39. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1990; 163; 1147-50.
40. Bussel JB, Druzin ML, Cines DB, Samuels P. Thrombocytopenia in pregnancy. Lancet 1991; 337: 251.
41. Payne SD, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997; 177: 149-55.
42. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT et al. Estimate of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323: 229-35.
43. Matthews JH, Benjamin S, Gill DS, Smith MA. Pregnancy associated thrombocytopenia: definition, incidence and natural history. Acta Haematol 1990; 84: 24-29.
44. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988; 319: 142-45.
45. Lescale KB, Eddleman KA, Cines D, Samuels P, Tomaski A, Lesser M et al. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol 1996; 174: 1014-18.
46. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731-34.
47. Moutet A, Fromont P, Farcet JP, Rotten D, Bettaieb G, Duedari N et al. Pregnancy in women with immune thrombocytopenic purpura. Arch Intern Med 1990; 150: 2141-45.
48. Yamada H, Fujimoto S. Perinatal management of idiopathic thrombocytopenic purpura in pregnancy: risk factors for passive immune thrombocytopenia. Ann Hematol 1994; 68: 39-42.
49. a (HPA-5b) incompatibility causes thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura. Submitted. Am J Pediatr Hematol Oncol 1998.
50. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune thrombocytopenia working group. Blood 1997; 89: 4402-406.
51. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996; 88: 194-201.
52. Stockelberg D, Hou M, Jacobsson S, Kutti J, Wadenvik H. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA. Eur J Haematol 1996; 56: 72-77.
53. a. Vox Sang 1988; 54: 101-106.
54. Scott JR, Cruikshank DP, Kochenour NK, Pitkin RM, Warenski JC. Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura. Am J Obstet Gynecol 1980; 136: 495-99.
55. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463-66.
56. Kelton JG. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med 1983; 99: 796-800.
57. Jones RW, Asher MI, Rutherford CJ, Munro HM. Autoimmune idiopathic thrombocytopenic purpura in pregnancy and the newborn. Br J Obstet Gynaecol 1977; 84: 679-83.
58. Christiaens GCML, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 1997; 90: 546-52.
59. Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991; 78: 578-83.
60. Tchernia G, Morel-Kopp MC, Yvart J, Kaplan C. Neonatal thrombocytopenia and hidden maternal autoimmunity. Br J Haematol 1993; 84: 457-63.
61. Territo M, Finklestein J, Oh W, Hobel C, Kattlove H. Management of autoimmune thrombocytopenia in pregnancy and in the neonate. Obstet Gynecol 1973; 41: 579-84.
62. Cines DB, Dusak B, Tomaski A, Mennuti M, Schreiber AD. Immune thrombocytopenic purpura and pregnancy. N Engl J Med 1982; 306: 826-31.
63. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5194 fetal blood samplings. Blood 1994; 84: 1851-56.
64. Scioscia AL, Grannum PAT, Copel JA, Hobbins JC. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol 1988; 159: 1066-68.
65. Moise KJ, Carpenter RJ, Cotton DB, Wasserstrum N, Kirshon B, Cano L. Percutaneous umbilical cord blood sampling in the evaluation of fetal platelet counts in pregnant patients with autoimmune thrombocytopenic purpura. Obstet Gynecol 1988;72: 346-50.
66. Krye JJ, Corrigan JJ. Idiopathic thrombocytopenic purpura during pregnancy: a pediatric viewpoint. Am J Pediatr Hematol Oncol 1983; 5: 21-25.
67. Pachi A, Carapella E, Mazzucconi MG, Gandolfo GM, Paesano R, Petrelli V et al. Autoimmune thrombocytopenic purpura: maternal and fetal disease. Early Hum Dev 1992; 29: 143-47.
68. Scott JR, Rote NS, Cruikshank DP. Antiplatelet antibodies and platelet counts in pregnancies complicated by autoimmune thrombocytopenic purpura. Am J Obstet Gynecol 1983; 145: 932-36.
69. Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons JC et al. Fetal platelet counts in thrombocytopenic pregnancy. Lancet 1990; 336: 979-82.
70. Bussel JB, Tanli S, Peterson HC. Favorable neurological outcome in 7 cases of perinatal intracranial hemorrhage due to immune thrombocytopenia. Am J Pediatr Hematol Oncol 1991; 13: 156-59.
71. Silver RM, Branch DW, Scott JR. Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol 1995; 173: 479-82.
72. Skupski DW, Bussel JB. Further insights into autoimmune thrombocytopenia in pregnancy. Am J Obstet Gynecol 1996; 174: 1944-45.
73. Christiaens GCML, Helmerhorst FM. Validity of intrapartum diagnosis of fetal thrombocytopenia. Am J Obstet Gynecol 1987; 157: 864-65.
74. Adams DM, Bussel JB, Druzin ML. Accurate intrapartum estimation of fetal platelet count by fetal scalp sample smear. Am J Perinatol 1994; 11: 42-45.
75. Moise KJ, Patton DE, Cano LE. Misdiagnosis of a normal fetal platelet count after coagulation of intrapartum scalp samples in autoimmune thrombocytopenic purpura. Am J Perinatol 1991; 8: 295-96.
76. Bussel JB, Kaplan C, McFarland J. Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the International Society of Thrombosis and Haemostasis: recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. Thromb Haemost 1991; 65: 631-34.
77. Christiaens GC, Nieuwenhuis HK, von dem Borne AE, Ouwehand WH, Heimerhorst FM, van Dalen CM, van der Tweel I. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990; 97: 893-98.
78. Urbaniak SJ, Duncan I, Armstrong-Fisher SS, Abramovich DR, Page KR. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: a possible mechanism of action. Br J Haematol 1997; 96: 186-93.
79. Bussel JB, Berkowitz RL, McFarland JG. Maternal IVIG in neonatal alloimmune thrombocytopenia. Br J Haematol 1997; 98: 493-94.